CircRNA ZFR promotes cell progression by regulating miR-96a-5p/SLC1A1 axis in hepatocellular carcinoma

  • 0CAS Key Lab of Bio-Medical Diagnostics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Science, Suzhou, 215163, China. cedric_bongolo@whu.edu.cn.

|

|

Summary

This summary is machine-generated.

Circular RNA ZFR (circRNA ZFR) is upregulated in hepatocellular carcinoma (HCC), promoting tumor growth and metastasis. Knockdown of circRNA ZFR inhibits HCC progression by targeting the miR-96a-5p/SLC1A1 pathway, offering potential therapeutic strategies.

Area Of Science

  • Oncology
  • Molecular Biology
  • Biochemistry

Background

  • Circular RNA ZFR (circRNA ZFR) dysregulation is implicated in hepatocellular carcinoma (HCC) progression.
  • The precise molecular mechanisms underlying circRNA ZFR's role in HCC remain incompletely understood.

Purpose Of The Study

  • To investigate the expression and functional role of circRNA ZFR in HCC.
  • To elucidate the molecular mechanism of circRNA ZFR, including its interactions with miR-96a-5p and SLC1A1, in HCC progression.

Main Methods

  • Quantitative real-time PCR (qRT-PCR) and Fluorescent In Situ Hybridization for circRNA ZFR expression analysis.
  • Cell proliferation, migration, and invasion assays (colony formation, Transwell, wound healing).
  • Luciferase reporter assays, western blot, and Chromatin Isolation by RNA Purification/Mass Spectrometry (CHIRP/MS) to investigate molecular interactions.

Main Results

  • CircRNA ZFR was significantly upregulated in HCC clinical samples and cells, correlating with tumor differentiation, size, and TNM stage.
  • Overexpression of circRNA ZFR promoted HCC cell proliferation, migration, and invasion; conversely, its knockdown inhibited these processes.
  • CircRNA ZFR acts as a sponge for miR-96a-5p, and this interaction modulates SLC1A1 expression, ultimately affecting HCC progression.

Conclusions

  • CircRNA ZFR knockdown retards HCC progression by sponging miR-96a-5p and modulating SLC1A1 expression.
  • The circZFR/miR-96a-5p/SLC1A1 axis represents a potential therapeutic target for hepatocellular carcinoma.

Related Concept Videos

Abnormal Proliferation 02:23

4.6K

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Role Of Notch Signalling In Intestinal Stem Cell Renewal 01:12

2.2K

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

mTOR Signaling and Cancer Progression 03:03

3.9K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

MAPK Signaling Cascades 01:07

6.1K

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...